News

Gestalt Diagnostics and Flagship Biosciences Announce Strategic Relationship to Deliver Integrated Image Analysis for PD-L1 Testing

Spokane, WA, and Westminster, CO – September 26, 2019 – Gestalt Diagnostics and Flagship Biosciences today announced their collaboration in the development of an integrated workflow for pathologists to access Flagship’s Image Analysis services for digital images to support PD-L1 testing. The companies are providing a more efficient diagnostic process by engaging in a shared service to add Flagship’s computational services to Gestalt’s digital pathology solution, PathFlow™.

Download the Press Release

Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.

Sign Up Today

Recent Posts

Scientist Spotlight: Lenka Sinik, PhD

In this Scientist Spotlight, we sit down with Lenka Sinik, Head of the Science Team in Colorado, to discuss her journey into science, the excitement of working at the intersection of technology and precision medicine, and how her expertise is helping biopharma...

Scientist Spotlight: Roger Pearce, MS

Roger Pearce is an Image Analysis Services Manager at Flagship Biosciences. Through expertise in Image Analysis and Digital Pathology, Pearce and his team strive to solve problems for both internal and external clients, pushing their skills and technology to their...

Scientist Spotlight: David Henderson, PhD

Dr. Henderson is Vice President of Computational & Imaging Sciences at Flagship. With a passion for innovative technology and solving problems for clients, Dr. Henderson not only inspires his team but also pushes the boundaries of what’s possible in our industry....

Flagship Biosciences Is Honored with a Best Practices Award

We are honored to announce that Flagship Biosciences has earned a Frost & Sullivan 2023 North American Customer Value Leadership Award in the AI-enabled digital pathology solutions market. Following from detailed evaluation of best practices criteria, the award...